THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation.
Xu HH, Hao SX, Sun HY, Dong XX, Lin Y, Lou H, Zhao LM, Tang PP, Dou ZJ, Han JJ, Du MH, Chen ZX, Kopylov P, Shchekochikhin D, Liu X, Zhang Y.
Xu HH, et al. Among authors: dou zj.
Acta Pharmacol Sin. 2024 Jun 11. doi: 10.1038/s41401-024-01307-7. Online ahead of print.
Acta Pharmacol Sin. 2024.
PMID: 38862818